TIFFANY GEORGE
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology WESTON, FL NPI 1780004283
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology FL GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$3,907.99
- Category: General Payments
- Program years: PY2020–2024
- Record count: 165
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,494.68 across 70 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,494.68 | 70 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $187.66 | 5 |
| PFIZER INC. | $170.26 | 11 |
| Janssen Biotech, Inc. | $164.78 | 4 |
| Merck Sharp & Dohme Corporation | $134.83 | 9 |
| Daiichi Sankyo Inc. | $126.70 | 5 |
| Acerta Pharma LLC | $109.12 | 5 |
| TAIHO ONCOLOGY, INC. | $103.86 | 5 |
| Takeda Pharmaceuticals U.S.A., Inc. | $50.95 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $49.14 | 3 |
| ARRAY BIOPHARMA INC | $46.04 | 3 |
| Stemline Therapeutics Inc. | $45.58 | 2 |
| GENZYME CORPORATION | $36.99 | 2 |
| EMD Serono, Inc. | $34.75 | 2 |
| ABBVIE INC. | $30.52 | 1 |
| AVEO Pharmaceuticals, Inc. | $24.71 | 1 |
| TerSera Therapeutics LLC | $24.20 | 1 |
| Genentech USA, Inc. | $22.77 | 1 |
| Ipsen Biopharmaceuticals, Inc | $22.29 | 1 |
| Tempus AI, Inc | $21.22 | 1 |
| SpringWorks Therapeutics, Inc. | $18.66 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.48 | 1 |
| Lilly USA, LLC | $17.39 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.12 | 1 |
| BeiGene USA, Inc. | $16.66 | 1 |
By program year
Records — PY2024 (70)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.